TherapeuticsMD Inc (TXMD) Company Profile & Statistics

TherapeuticsMD Inc
TXMD
(Nasdaq - US)
N/A
1.90
+0.02 (+0.80%)
in:usd•As of: May 02, 2024 15:49 UTC -4
Open
1.90
High
1.90
Low
1.90

About TherapeuticsMD Inc

CEO

Marlan D. Walker

Headquarters

951 yamato road, suite 220

boca raton, fl 33431, united states

Auditor

GRANT THORNTON LLP

Employees

Share Holders

Website

www.therapeuticsmd.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.

TherapeuticsMD Inc Statistics

Valuation Measures

Market Capitalization ²	21.91M
Enterprise Value	17.58M
Enterprise Value/EBITDA (ttm)	-2.31
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.68
Price to Sales (ttm)	0.24
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	1194.80%
Return on Equity (ttm)	-25.54%
Return on Invested Capital (ttm)	-25.32%
Return on Assets (ttm)	-14.87%

Income Statement

Revenue (ttm)	1.30M
Revenue Per Share (ttm)	0.11
Gross Profit (ttm)	1.30M
EBITDA (ttm)³	-7.60M
Net Income Avi to Common (ttm)	-10.28M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	1.07
52-Week Change	-50.39%
S&P500 52-Week Change	24.86%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	11.53M
Dividend Yield	0.00%
Float ⁴	11.39M
% Held by Insiders	1.20%
% Held by Institutions	30.74%

Balance Sheet

Total Cash (mrq)	4.33M
Total Cash Per Share (mrq)	0.38
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	1.72%
Quick Ratio (mrq)	1.72%
Book Value Per Share (mrq)	2.54

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.21
Free Cash Flow (ytd)	-23.08M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

TherapeuticsMD Inc

Trade With A Regulated Broker